Horizon Pharma Plc (HZNP)

23.18
0.25 1.10
NASDAQ : Health Technology
Prev Close 22.93
Open 23.07
Day Low/High 22.87 / 23.18
52 Wk Low/High 12.55 / 24.03
Volume 1.95M
Avg Volume 1.46M
Exchange NASDAQ
Shares Outstanding 167.63M
Market Cap 3.86B
EPS -2.50
P/E Ratio N/A
Div & Yield N.A. (N.A)
Horizon Pharma (HZNP) In A Perilous Reversal

Horizon Pharma (HZNP) In A Perilous Reversal

Trade-Ideas LLC identified Horizon Pharma (HZNP) as a "perilous reversal" (up big yesterday but down big today) candidate

A Small Pharma Stock With Big Potential

A Small Pharma Stock With Big Potential

Pernix looks poised for a strong 2016.

Horizon Pharma (HZNP) Strong On High Relative Volume Today

Horizon Pharma (HZNP) Strong On High Relative Volume Today

Trade-Ideas LLC identified Horizon Pharma (HZNP) as a strong on high relative volume candidate

How to Build a Good Foundation in Biotechs

How to Build a Good Foundation in Biotechs

A so-called "pyramid strategy" can help you enter the depressed sector.

Perilous Reversal Watch: Horizon Pharma (HZNP)

Perilous Reversal Watch: Horizon Pharma (HZNP)

Trade-Ideas LLC identified Horizon Pharma (HZNP) as a "perilous reversal" (up big yesterday but down big today) candidate

Horizon Pharma (HZNP) Is Today's Dead Cat Bounce Stock

Horizon Pharma (HZNP) Is Today's Dead Cat Bounce Stock

Trade-Ideas LLC identified Horizon Pharma (HZNP) as a "dead cat bounce" (down big yesterday but up big today) candidate

Jim Cramer's 'Mad Money' Recap: Here's the Silver Lining Behind the Dark Market Cloud

Jim Cramer's 'Mad Money' Recap: Here's the Silver Lining Behind the Dark Market Cloud

Stocks get cheaper as they head lower and every day we're inching closer to a bottom, Cramer says.

Hedge Funds Doing Battle Over Ailing Stocks

There's blood in the water.

Horizon Pharma (HZNP): Today's Weak On High Volume Stock

Horizon Pharma (HZNP): Today's Weak On High Volume Stock

Trade-Ideas LLC identified Horizon Pharma (HZNP) as a weak on high relative volume candidate

The Biotechs Are Being Taken Out and Shot

All you can do is wait until they bottom out.

Horizon and ANI Appeal in Pharma Selloff

Horizon and ANI Appeal in Pharma Selloff

Some smaller biotechs offer good value at current levels.

Today's Dead Cat Bounce Stock: Horizon Pharma (HZNP)

Today's Dead Cat Bounce Stock: Horizon Pharma (HZNP)

Trade-Ideas LLC identified Horizon Pharma (HZNP) as a "dead cat bounce" (down big yesterday but up big today) candidate

Market Wrap: Stocks Sink Across the Board

Materials and technology names led the way down on the session.

Horizon Pharma (HZNP) Showing Signs Of Being A Roof Leaker

Horizon Pharma (HZNP) Showing Signs Of Being A Roof Leaker

Trade-Ideas LLC identified Horizon Pharma (HZNP) as a "roof leaker" (crossing below the 200-day simple moving average on higher than normal relative volume) candidate

Analysts Say Buy Select Biotech Stocks Ahead Of Clinton Drug Plan

Analysts Say Buy Select Biotech Stocks Ahead Of Clinton Drug Plan

Analysts at research firms Jefferies and Piper Jaffray are recommending select biotech stocks that they view as buys amid the weakness in the space.

Horizon Pharma (HZNP) Is Today's Water-Logged And Getting Wetter Stock

Horizon Pharma (HZNP) Is Today's Water-Logged And Getting Wetter Stock

Trade-Ideas LLC identified Horizon Pharma (HZNP) as a "water-logged and getting wetter" (weak stocks crossing below support with today's range greater than 200%) candidate

Horizon and Depomed Sue Each Other Over Takeover Tactics

Horizon and Depomed Sue Each Other Over Takeover Tactics

The pharma companies faced off in Calfironia over Horizon's rejected $2 billion hostile takeover.

Horizon Pharma (HZNP) In A Perilous Reversal

Horizon Pharma (HZNP) In A Perilous Reversal

Trade-Ideas LLC identified Horizon Pharma (HZNP) as a "perilous reversal" (up big yesterday but down big today) candidate

Horizon Raises Bid for Specialty Pharma Company Depomed

Horizon Raises Bid for Specialty Pharma Company Depomed

The offer comes just three months after Depomed purchases the diabetes-related pain drug Nucynta from a subsidiary of Johnson & Johnson.

'Mad Money' Lightning Round: You Want Yahoo!

'Mad Money' Lightning Round: You Want Yahoo!

Cramer says to stay away from Alibaba but go for Yahoo!

Jim Cramer's 'Mad Money' Recap: Earnings Tsunami Heads Our Way

Jim Cramer's 'Mad Money' Recap: Earnings Tsunami Heads Our Way

Cramer says you've got to listen to the commentary on earnings from Apple tomorrow, not to mention what's up with Microsoft and falling PC sales.

Use Options For a Chance To Buy HZNP at a 44% Discount

Use Options For a Chance To Buy HZNP at a 44% Discount

Looking back to 96 days ago, Horizon Pharma plc priced a 15,350,000 share secondary stock offering at $28.25 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time and based on early trading on Monday, the stock is now 35.6% above the offering price.

Horizon Pharma (HZNP) Stock Gains on Strong Guidance

Horizon Pharma (HZNP) Stock Gains on Strong Guidance

Horizon Pharma (HZNP) shares are rising after the company provided upside second quarter and full year revenue guidance.

Strong Upward Pre-Market Activity For Horizon Pharma (HZNP)

Strong Upward Pre-Market Activity For Horizon Pharma (HZNP)

Trade-Ideas LLC identified Horizon Pharma (HZNP) as a pre-market leader candidate

Will Horizon Pharma (HZNP) Stock be Hurt by DepoMed's Poison Pill?

Will Horizon Pharma (HZNP) Stock be Hurt by DepoMed's Poison Pill?

Horizon Pharma (HZNP) shares are showing volatility after the object of its takeover interest, DepoMed (DEPO), adopted a poison pill to dissuade any further unsolicited offers.

Horizon Pharma (HZNP) Hits New Lifetime High

Horizon Pharma (HZNP) Hits New Lifetime High

Trade-Ideas LLC identified Horizon Pharma (HZNP) as a new lifetime high candidate

Market Wrap: Stocks Make Quick Recovery

Second-half rebound erases losses.

Stocks Close Higher on Hopes Greece Reaches Deal Soon

Stocks Close Higher on Hopes Greece Reaches Deal Soon

After a volatile session, stocks close positive as investors cling to hopes that Greece puts forth a suitable debt proposal, expected Wednesday.

Stocks Turn Positive on Hopes for Greece Reforms

Stocks Turn Positive on Hopes for Greece Reforms

U.S. stocks turn positive in late trading on Tuesday, with reports saying Greece has proposed a solution to keep the country afloat for July.

Horizon Pharma (HZNP) Stock Sinks After DepoMed Rejects Unsolicited $3 Billion Bid

Horizon Pharma (HZNP) Stock Sinks After DepoMed Rejects Unsolicited $3 Billion Bid

Horizon Pharma (HZNP) shares are declining after rival DepoMed (DEPO) rejected the company's $3 billion merger bid today.

TheStreet Quant Rating: B- (Buy)